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A B S T R A C T
Background: Pain is associated with depression in nursing home patients with dementia. It is, however, unclear
whether pain increases depression. Therefore we evaluated the prospective associations between pain and
depressive symptoms in nursing home patients at diﬀerent stages of cognitive impairment.
Methods: Two longitudinal studies were combined, including 931 patients (≥65 years) from 65 nursing homes.
One study assessed patients at admission, with 6-month follow-up (2012–2014). The other study assessed
residents with varying lengths of stay, with 4-month follow-up (2014–2015). Patients were assessed with the
Mini-Mental State Examination, the Mobilisation-Observation-Behaviour-Intensity-Dementia-2 Pain Scale, and
the Cornell Scale for Depression in Dementia.
Results: At baseline, 343 patients (40% of 858 assessed) had moderate to severe pain, and 347 (38% of 924) had
depression. Pain increased the risk of depression (OR 2.35, 95% CI 1.76–3.12). Using mixed model analyses, we
found that a 1-point increase in pain was associated with a .48 increase in depression (p< .001). This
association persisted in mild, moderate, and severe cognitive impairment. In those recently admitted, depressive
symptoms decreased over time, and having less pain at follow-up was associated with a decrease in depressive
symptoms (within-subject eﬀect; p=.042).
Limitations: The two cohorts had diﬀerent inclusion criteria, which may reduce generalisability. The study
design does not allow conclusions on causality.
Conclusions: Pain and depressive symptoms are associated in patients with dementia. Because reduced pain is
associated with less depressive symptoms, these patients should be assessed regularly for untreated pain. The
beneﬁt of analgesic treatment should be weighed carefully against the potential for adverse eﬀects.
1. Introduction
In Norway, over 80% of nursing home patients have dementia
(Helvik et al., 2015). Symptoms of depression aﬀect up to 50% of
people with dementia, causing increased suﬀering, reduced quality of
life, and possibly shortened life expectancy (Enache et al., 2011;
Gonzalez-Salvador et al., 2000; Janzing et al., 1999; Todd et al.,
2013). Depression in people with dementia may also accelerate the
decline in daily functioning and cognition, and contribute to the loss of
independence and earlier nursing home placement (Luppa et al., 2008;
Potter and Steﬀens, 2007; Rapp et al., 2011). Over time, depression
often persists and re-occurs in these individuals (Selbaek and Engedal,
2012; Selbaek et al., 2013), and may be associated with worse outcomes
of medical treatment (Bellelli et al., 2008; Lenze et al., 2007; Smith
et al., 2015).
To manage mild to moderate depression in people with dementia,
nonpharmacological interventions such as psychotherapy, reminiscence
therapy, and personalized pleasant activities are recommended as ﬁrst-
line treatment (Kales et al., 2015; Orgeta et al., 2015; Testad et al.,
2014). In severe depression, pharmacological treatment with antide-
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pressants is recommended, although updated systematic reviews of the
use of antidepressants for depression in people with dementia did not
ﬁnd conclusive evidence for eﬃcacy in this population (Leong, 2014;
Nelson and Devanand, 2011).
Thus far, little attention has been paid to potential modiﬁable causal
factors of depression such as untreated chronic pain. Approximately
40–60% of nursing home patients are suggested to be in daily moderate
to severe pain (Achterberg et al., 2010; Husebo et al., 2011). People
with dementia are at particular risk of untreated pain because their
ability to understand, evaluate, and verbally communicate symptom
severity gradually decreases (Flo et al., 2014). This may trigger
symptoms such as depression, agitation, and sleep problems (Ballard
et al., 2009). The interrelationship between pain and depression,
known as the “pain-depression dyad”, is well documented in people
without dementia (Bair et al., 2003; Goldenberg, 2010). Although no
clear aetiology has been established, the conditions are known to
commonly coexist, mutually exacerbate each other, share common
signal pathways and neurotransmitters, and respond to similar treat-
ments (Chopra and Arora, 2014).
The pain-depression dyad is not suﬃciently investigated in people
with dementia (Bair et al., 2003; Goldenberg, 2010). Thus far, four
cross-sectional studies have found a signiﬁcant association between
pain and depression in nursing home patients with moderate to severe
dementia (Cipher and Cliﬀord, 2004; Leong and Nuo, 2007; Malara
et al., 2016; Williams et al., 2005), including one study which also
reported the prevalence of pain and depression stratiﬁed by cognitive
status (Leong and Nuo, 2007). The most recent study by Malara et al.
(2016) included 233 patients at diﬀerent stages of dementia and found
a signiﬁcant association between pain and depression as evaluated by a
physician. Although these studies provide important insights, some had
a low sample size, did not assess pain and/or depression with validated
proxy-rated instruments, and all studies lack prospective data to
evaluate whether pain is associated with future worsening of depres-
sion. In the current study, we investigate the prospective associations
between pain and depression in nursing home patients with advanced
dementia to explore whether pain may be an exacerbating factor for
depression, or vice versa. We addressed the following research ques-
tions: i) Is the intensity of pain associated with the severity of
depression? ii) Is change in pain over time associated with change in
depression? iii) How are these associations aﬀected by cognitive
function and use of analgesic or antidepressant drugs?
2. Methods
2.1. Sample
We analysed prospective data from two independent multicentre
studies in 6 counties of Norway. The REDIC (REsource Use and DIsease
Course in Dementia) study included all patients aged ≥65 years (or
younger, if established dementia diagnosis) at admission to nursing
home care with an expected stay of> 4 weeks, and life expectancy> 6
weeks, from January 2012 to June 2014 (Sandvik et al., 2016a). In
total, 696 patients were included from 47 nursing homes. The current
analyses use data collected at month 0 and 6, excluding 12 patients
aged<65 years (Fig. 1). The other study, COSMOS (COmmunication,
Systematic pain treatment, Medication review, Organized activities and
Safety), included all patients aged ≥65 years in long-term nursing
home care, excluding patients with diagnosis of schizophrenia or life
expectancy<6 months, from April 2014 to June 2015 (Husebo et al.,
2015). In total, 545 patients were included from 67 units (clusters) in
31 nursing homes. Clusters were randomised to receive either a
complex intervention or care as usual (Husebo et al., 2015). The
current analyses use data from the control group, comprising 247
patients from 26 units, collected at month 0 and 4 (Fig. 1).
2.2. Data collection
Data collection in both studies was completed in close collaboration
with a staﬀ member who had been familiar with the patients for a
minimum of 4 weeks prior to data collection. The staﬀ received training
in the appropriate use of each outcome measure (Table 1), and had
assistance from the researchers as needed. Demographic information
and scheduled drug prescriptions (excluding prescriptions given “as
needed”) were extracted from the patients’ medical records. Analgesic
use at baseline and follow-up was assessed by counting the number of
prescriptions for drugs classiﬁed as systemic analgesics (Anatomical
Therapeutic Chemical (ATC) code N02 or M01A) at each time point.
Similarly, antidepressant use was assessed by counting the number of
prescriptions for drugs classiﬁed as antidepressants (ATC code N06A) at
baseline and follow-up. We did not assess the appropriateness of dose;
i.e. a dose adjustment from baseline to follow-up was not registered.
Cognitive function was assessed using the Mini-Mental State
Examination (MMSE), with scores from 26 to 30 deﬁned as no/
questionable, 21–25 as mild, 11–20 as moderate and 0–10 as severe
cognitive impairment (Folstein et al., 1975; Perneczky et al., 2006).
Pain was assessed using the Mobilisation-Observation-Behaviour-Inten-
sity-Dementia-2 (MOBID-2) Pain Scale, with moderate to severe pain
deﬁned as a score of ≥3 (Husebo et al., 2014). Depressive symptoms
were assessed using the Cornell Scale for Depression in Dementia
(CSDD), and depression deﬁned as a score of ≥8 (Alexopoulos et al.,
1988; Burns et al., 2004). The Neuropsychiatric Inventory – Nursing
Home version (NPI-NH) was used to assess neuropsychiatric symptoms
(Cummings et al., 1994; Selbaek et al., 2008), and the NPI-depression
subscale was used as a secondary outcome measure.
2.3. Statistical analysis
Baseline characteristics were described with mean and standard
deviation (SD) for continuous variables and with number of patients
and percentages of sample size for categorical variables. Diﬀerences at
baseline between the studies were tested with independent samples t-
tests for normally distributed continuous variables, Mann-Whitney U-
test for non-normal distributed continuous variables and Pearson χ2
tests for categorical variables. The unadjusted odds ratio (OR) for
depression among patients with moderate to severe pain was calculated
at baseline. Linear regression models were ﬁtted to analyse the
prospective association between pain at baseline and depression at
follow-up, and vice versa, adjusted for depression, pain, age, sex, and
cognitive function at baseline. To account for intra-cluster correlation
Fig. 1. Patients included in the ﬁnal analyses.
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at the nursing home level, we used robust estimators for variance. To
explore whether increasing pain was associated with increasing depres-
sion, and vice versa, we used linear mixed eﬀect models with restricted
maximum likelihood estimation. We conducted several analyses for the
outcome variables where we included ﬁxed eﬀects for MOBID-2, CSDD,
time, antidepressant use, and analgesic use (time-varying covariates),
and MMSE, age, and sex (time-constant variables). Associations at
diﬀerent stages of cognitive functioning were assessed by stratifying
according to MMSE (Perneczky et al., 2006). To account for intra-
cluster correlation, the models were ﬁtted with random intercept for
both nursing home and patient-level eﬀects. We included random slope
for MOBID-2 and CSDD at patient-level, thus allowing the eﬀects of
these covariates to vary between patients. The covariance structures
were speciﬁed using an independent model for both patients and
nursing homes. The regression coeﬃcients for the time-varying covari-
ates can be interpreted as a between-patients eﬀect and/or a within-
patient eﬀect. To investigate this further, we included both within and
between eﬀects in the same model (Rabe-Hesketh and Skrondal, 2012).
Mixed model analyses were also conducted using NPI-depression as a
dependent variable, with MOBID-2, time, MMSE, age, and sex as
independent variables, to explore whether any associations obtained
using the CSDD scale were replicated. We regarded p< .05 as
statistically signiﬁcant. All analyses were conducted with Stata/IC
version 14 (StataCorp LP, College Station, TX, USA).
2.4. Ethical and legal considerations
Verbal and written informed consent was obtained from the patients
if they had suﬃcient ability to consent; if not, written presumed consent
was obtained from a legally authorised representative, in accordance
with the ethics committee requirements and current Norwegian legisla-
tion. The REDIC and COSMOS trials were approved by the Regional
Committees for Medical and Health Research Ethics, 2011/1738 and
2013/1765, and registered at clinicaltrials.gov, NCT01920100 and
NCT02238652, respectively.
3. Results
We included 931 patients with a mean age of 85.4 (SD 7.0) and
mean MMSE score of 14.6 (SD 7.1); 622 (66.8%) were women
(Table 2). In total, 703 completed the follow-up assessments, 142 died,
39 moved home or to a diﬀerent institution/ward, 5 withdrew consent
to participate, and 42 were lost to follow-up for other reasons (Fig. 1).
Compared to the REDIC study, participants included in the COSMOS
trial were older and had a higher ratio of women. They had lower
MMSE scores, more pain and depressive symptoms, neuropsychiatric
symptoms, and used more analgesics and antidepressants. At baseline,
343 of all patients (40.0% of those who completed the assessment) had
moderate to severe pain (MOBID-2≥3), 347 (37.6%) had depression
(CSDD≥8), and 164 (19.2% of 856 patients who completed both
assessments) had both pain and depression. The unadjusted OR of
patients with moderate to severe pain having depression was 2.35 (95%
CI 1.76–3.12). MOBID-2 assessments at baseline and follow-up were
completed by 617 patients, of whom 137 (22.2%) had moderate to
severe pain at both assessments. Mean pain score was unchanged from
baseline to follow-up, and 92 patients (14.9%) had new incidence
moderate to severe pain at follow-up. CSDD assessments at baseline and
follow-up were completed for 699 patients, of whom 144 (20.6%) had
depression at both assessments, and 81 patients (11.6%) had new
incidence depression at follow-up.
Using linear regression, we found that pain at baseline was
signiﬁcantly associated with depression at follow-up in both the
REDIC and COSMOS groups (coeﬃcients .26 and .70, p=.022 and<
.001, respectively). When adjusting for covariates, this association
remained signiﬁcant only in the COSMOS group (Table 3). Similarly,
depression at baseline was signiﬁcantly associated with pain at follow-
up in both groups in the unadjusted analyses (coeﬃcients .06 and .11
for REDIC and COSMOS, respectively, p< .001), but only signiﬁcantly
in the REDIC group (coeﬃcient .05, p=.008) after adjusting for
covariates.
Using linear mixed model analyses, adjusted for time (months),
MMSE, age, and sex, we found that patients with more pain were
signiﬁcantly more depressed than those with less pain, and vice versa
(Model 2, Table 4). An increase of 1 on the MOBID-2 scale was
associated with an increase of .48 on the CSDD scale (p< .001) and
with an increase of .11 on the NPI-depression subscale (p=.005). An
increase of 1 on the CSDD scale was associated with an increase of .10
on the MOBID-2 scale (p< .001). When measures of between- and
within-subject eﬀects were included in the model, only the between-
subject eﬀects were signiﬁcant (p< .001 for between-, and p=.113 for
within-subject eﬀects). Over time, depression scores decreased in
severity (.10 decrease in CSDD scores per month, p=.007), as opposed
to pain which remained unchanged. The severity of pain and depression
was gender independent (coeﬃcients .26, p=.069; −.08, p=.814;
respectively). Older patients had more pain (coeﬃcient .02, p=.014)
but less depression (−.10, p< .001), and those with more severe
cognitive impairment had more depression (1 point less on the MMSE
scale was associated with .12 increase in CSDD, p< .001), but not more
pain (coeﬃcient .00, p=.721). However, the progression of depression
over time (Fig. 2) was not aﬀected by MMSE score (p=.990). The
mixed model analyses were re-calculated separately for the REDIC and
COSMOS groups with unchanged results, except that the COSMOS
Table 1
Assessment scales.
What does the tool measure? Tool characteristics and psychometric properties
MMSE Staging of cognitive impairment based on scores in 8 domains (orientation to
time and place, short-term recall, attention, calculation, long-term recall,
language, repetition, and complex commands), questionnaire administered
directly to the patient
30 items yield a sum score from severe (0–10), moderate (11–20), mild
(21–25), to no cognitive impairment (26–30) (Folstein et al., 1975). Widely
used as a screening tool, with good reliability and validity (Tombaugh and
McIntyre, 1992).
MOBID-2 Pain
Scale
Assessment of pain intensity in dementia inferred by observation of pain
behaviours during standardised, guided movement (part 1 - musculoskeletal
system; current) and previous observations of other pain behaviours (part 2 -
internal organs, head and skin; in the last days), proxy rated
Each item is rated on a horizontal scale from 0 (no pain) to 10 (worst pain
imaginable). Yields a ﬁnal assessment of total pain (range 0–10) (Husebo
et al., 2007). Excellent reliability and validity, good responsiveness (Husebo
et al., 2014). Total pain ≥3 was deﬁned as moderate to severe pain.
CSDD Depressive symptoms in people with dementia in 5 domains (mood-related
signs, behavioural disturbance, physical signs, cyclic functions, and ideational
disturbance) in the last week, proxy rated
19 items with each symptom score rated from 0 (not present) to 2 (severe)
(Alexopoulos et al., 1988). Satisfactory interrater reliability and validity in the
elderly population (Korner et al., 2006). Sum score ≥8 deﬁned as depression
(Burns et al., 2004).
NPI-NH The frequency and severity of 12 neuropsychiatric items in dementia
(delusions, hallucinations, agitation/aggression, depression/dysphoria,
anxiety, elation/euphoria, apathy/indiﬀerence, loss of inhibition, irritability/
lability, aberrant motor behaviours, sleep and appetite and eating
disturbances), proxy rated
The product of frequency (0–4) and severity (1–3) yields a composite score
per item from 0 (not present) to 12 (most frequent and severe symptoms),
with a cut-oﬀ value of ≥4 for clinically signiﬁcant symptoms. Sum score
0–144 (Cummings et al., 1994). The Norwegian version has shown good
reliability and validity (Selbaek et al., 2008).
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population did not have a signiﬁcant reduction in depressive symptoms
over time (coeﬃcient −.08, p=.474). The REDIC population had a
signiﬁcant within-subject eﬀect of pain on depressive symptoms, i.e. a
patient who had reduced pain at follow-up had signiﬁcantly less
depressive symptoms at follow-up compared to baseline (between-
subject coeﬃcient .62, p< .001, within-subject coeﬃcient .23,
p=.042). In the COSMOS population, only the between-subject eﬀects
were signiﬁcant (p=.317 for individual eﬀects).
The associations between pain and depressive symptoms remained
signiﬁcant when use of analgesics and/or antidepressants at baseline
and follow-up was included in the mixed models (Model 3–5, Table 4).
Use of analgesics was signiﬁcantly associated with pain and depression.
A patient who received an increased number of analgesics from baseline
to follow-up had signiﬁcantly increased pain (coeﬃcient .65, p< .001)
and increased depression (.49, p=.006) in the same period (Model 4,
Table 4). Number of prescribed antidepressants was signiﬁcantly
associated with depressive symptoms (1.2, p< .001), but not with
pain (−.02, p=.873) (Model 3, Table 4).
When patients were grouped according to cognitive function, pain
was signiﬁcantly associated with increased depression in people with
mild (coeﬃcient .47, p=.005) and moderate (.62, p< .001) cognitive
impairment, and near-signiﬁcantly in those with severe cognitive
impairment (.24, p=.050; Table 5), but not signiﬁcantly associated in
those with no/questionable impairment (.39, p=.232). Correspond-
ingly, depression was associated with pain in mild (.09, p=.008),
moderate (.12, p< .001), and severe (.06, p=.016) cognitive impair-
ment, but not in those with no/questionable impairment (.07, p=.229).
4. Discussion
4.1. Discussion
This study conﬁrms the continued existence of the pain-depression
dyad in nursing home patients irrespective of cognitive status.
Moreover, this study is the ﬁrst to show that reduced pain intensity is
associated with future reduction of depressive symptoms in this
population. This is the ﬁrst large-scale multicentre prospective study
investigating the associations between pain and depression over time in
nursing home patients at all stages of cognitive impairment, using
validated proxy-rated instruments with good validity, reliability, and
responsiveness, and controlling for intra-cluster correlation and use of
analgesics and/or antidepressants. The obtained OR of depression in
patients with moderate to severe pain (unadjusted OR 2.35, 95% CI
1.76–3.12) was similar to results from previous nursing home studies
(Cipher and Cliﬀord, 2004; Gruber-Baldini et al., 2005; Leong and Nuo,
2007; Malara et al., 2016; Williams et al., 2005).
Although we found that the association between pain and depres-
sive symptoms was strongest in patients with moderate cognitive
impairment (Table 5), the diﬀerence in eﬀect between the four stages
of cognitive impairment was not signiﬁcant (p=.227). This means that
we did not ﬁnd evidence to suggest that the association changed with
increasing severity of cognitive impairment. In patients with no/
questionable impairment, the association was nonsigniﬁcant, probably
because this group was smaller (n=49). Patients with severe cognitive
impairment appear to have a weaker association than those with
moderate impairment, which did not reach signiﬁcance despite this
group being relatively large (n=201), but the diﬀerence in eﬀect was
not signiﬁcant with the current sample size.
At baseline, 48% received one or more analgesics, while 40% still
had moderate to severe pain. A previous study found that in 2011, 58%
Table 2
Characteristics of included patients at baseline; total and between groups.
Total
(n=931)
N* REDIC (n=684) N* COSMOS (n=247) N* p
Agea 85.4 (7.0) 84.8 (6.8) 87.0 (7.2) < .001
Femaleb 622 (66.8%) 931 437 (63.9%) 684 185 (74.9%) 247 .002
MMSEa 14.6 (7.1) 15.7 (6.4) 11.4 (7.9) < .001
MMSE≤20b 673 (80.2%) 839 487 (78.2%) 623 186 (86.1%) 216 .012
MOBID-2c 2.3 (2.3) 2.1 (2.1) 2.8 (2.8) .008
MOBID-2≥3b 343 (40.0%) 858 249 (38.0%) 656 94 (46.5%) 202 .030
CSDDc 6.8 (5.6) 6.5 (5.2) 7.8 (6.4) .017
CSDD≥8b 347 (37.6%) 924 243 (35.7%) 681 104 (42.8%) 243 .049
NPI-NH total scorec 14.0 (17.0) 924 12.8 (15.3) 681 17.6 (20.7) 243 .012
NPI-NH depressionc 1.8 (3.1) 909 1.9 (3.1) 675 1.7 (3.1) 234 .448
Analgesicsb 445 (47.8%) 288 (42.1%) 157 (63.6%) < .001
Antidepressantsb 292 (31.4%) 193 (28.2%) 99 (40.1%) .001
Numbers represent mean (SD) or number of patients (%).
MMSE: Mini-Mental State Examination; NPI-NH: Neuropsychiatric Inventory-Nursing Home Version.
* Number of patients who completed each assessment.
a Independent-samples t-test.
b Pearson χ2-test.
c Mann-Whitney U-test.
Table 3
Linear regression; associations with pain and depression at follow-up.
Dependent
variable
Independent
variable
REDIC (n=453) COSMOS (n=158)
(follow-up) (baseline) Coef. p Coef. p
CSDD MOBID-2
(unadjusted)
.26 .022* .70 < .001*
CSDD MOBID-2 .08 .358 .41 .026*
CSDD .48 < .001* .49 < .001*
MMSE −.04 .357 −.07 .188
Sex .30 .347 .32 .802
Age −.08 .007* .01 .818
REDIC (n=439) COSMOS (n=138)
Coef. p Coef. p
MOBID-2 CSDD
(unadjusted)
.06 < .001* .11 < .001*
MOBID-2 CSDD .05 .008* .06 .064
MOBID-2 .38 < .001* .38 .005*
MMSE .03 .039* −.01 .849
Sex .13 .531 .37 .435
Age .01 .395 −.01 .800
COSMOS, COmmunication, Systematic pain treatment, Medication review, Organized activities
and Safety Study; CSDD, Cornell Scale for Depression in Dementia; MMSE, Mini-Mental
State Examination; MOBID-2, Mobilisation-Observation-Behaviour-Intensity-Dementia-2
Pain Scale; REDIC, REsource Use and DIsease Course in Dementia Study. Analyses include all
patients with valid assessments at baseline and follow-up, and are adjusted for intra-
cluster eﬀects at the nursing home level.
* Signiﬁcant association at p< .05 level.
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of nursing home residents in Norway were prescribed analgesics
(Sandvik et al., 2016b). While we found a lower overall prescription
rate, this is probably explained by the large proportion of recently
admitted nursing home patients in our sample. In the COSMOS group,
which is more comparable to the general nursing home population,
64% received analgesics. This may indicate a slight increase in
analgesic use from 2011 to 2014. A higher number of prescribed
analgesics at baseline, or an increase in the number of prescribed
analgesics from baseline to follow-up, was associated with higher levels
of both pain and depression. One explanation for this may be that the
prescribed treatment was insuﬃcient to relieve pain eﬀectively.
Another possibility is that use of one or more analgesics may increase
the total symptom burden due to adverse eﬀects or interactions
between analgesics or other psychotropic drugs such as sedatives.
Known adverse eﬀects of opioid analgesics in the elderly, such as
sedation or reduced appetite (Chau et al., 2008), may also have been
reported as symptoms of depression.
At baseline, 38% had depression and 31% received antidepressants.
A recent systematic review found that in Western nursing homes from
2004 to present, the use of antidepressants ranged from 18% to 48%,
and in the Nordic countries from 39% to 43% (Janus et al., 2016). In
the COSMOS sample, 40% used antidepressants, which is consistent
with these previous reports. Systematic reviews and meta-analyses have
not found clear beneﬁt of antidepressants for moderate to severe
depression in people with dementia (Leong, 2014; Nelson and
Devanand, 2011), despite this the rate of antidepressant use in nursing
home patients appears to remain unchanged (Gulla et al., 2016; Janus
et al., 2016). We found that antidepressant use was associated with
Table 4
Results from mixed model analyses; unstratiﬁed.
Dependent variable Independent variable Model 1 Model 2 Model 3 Model 4 Model 5
C p C p C p C p C p
CSDD MOBID-2 .45 < .001* .48 < .001* .48 < .001* .44 < .001* .44 < .001*
Time (months) −.11 .002 −.10 .007* −.11 .002* −.11 .003* −.12 .001*
MMSE −.12 < .001* −.12 < .001* −.12 < .001* −.12 < .001*
Age −.10 < .001* −.09 < .001* −.11 < .001* −.09 < .001*
Sex −.08 .814 −.30 .381 −.13 .711 −.32 .336
Antidepressants 1.2 < .001* 1.2 < .001*
Analgesics .49 .006* .41 .023*
MOBID-2 CSDD .09 < .001* .10 < .001* .10 < .001* .09 < .001 .09 < .001*
Time (months) .01 .560 .01 .398 .01 .393 .00 .927 .00 .973
MMSE .00 .721 .00 .715 .00 .795 .00 .768
Age .02 .014* .02 .015* .02 .052 .02 .065
Sex .26 .069 .26 .068 .18 .180 .19 .153
Antidepressants −.02 .873 −.08 .440
Analgesics .65 < .001* .65 < .001*
Model 1: Association between pain and depression over time, unadjusted; Model 2: Association between pain and depression over time, adjusted for cognitive function, age, and sex;
Model 3: Association between pain and depression over time, adjusted for number of prescribed antidepressants, cognitive function, age, and sex;Model 4: Association between pain and
depression over time, adjusted for number of prescribed analgesics, cognitive function, age, and sex;Model 5: Association between pain and depression over time, adjusted for number of
prescribed antidepressants and analgesics, cognitive function, age, and sex. C, coeﬃcient; CSDD, Cornell Scale for Depression in Dementia; MMSE, Mini-Mental State Examination;
MOBID-2, Mobilisation-Observation-Behaviour-Intensity-Dementia-2 Pain Scale. Analyses include all patients with valid assessments at any time point, and are adjusted for time to
follow-up (4/6 months) and intra-cluster eﬀects at the nursing home level.
* Signiﬁcant association at p< .05 level.
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Fig. 2. Mixed model; course of depressive symptoms by cognitive function.
Table 5
Mixed model, stratiﬁed for level of cognitive impairment.
Dependent
variable
Independent variable MMSE 0–10 (N=201) MMSE 11–20 (N=453) MMSE 21–25 (N=115) MMSE 26–30 (N=49) P-valuea
Coeﬃcient p Coeﬃcient p Coeﬃcient p Coeﬃcient p
CSDD MOBID-2 .24 .050 .62 < .001* .47 .005* .39 .232 .227
Time (months) −.08 .322 −.10 .042* −.13 .156 −.10 .436 .978
Sex .72 .392 −.45 .290 −.03 .967 .65 .706 .700
Age −.09 .086 −.09 .006* −.13 .019* −.11 .284 .830
MOBID-2 CSDD .06 .016* .12 < .001* .09 .008* .07 .229 .381
Time (months) −.06 .161 .04 .033* .02 .626 .00 .985 .165
Sex .49 .126 .09 .612 −.12 .751 1.5 .018* .024*
Age .04 .076 .02 .096 .00 .871 .01 .762 .417
CSDD, Cornell Scale for Depression in Dementia; MMSE, Mini-Mental State Examination; MOBID-2, Mobilisation-Observation-Behaviour-Intensity-Dementia-2 Pain Scale. Analyses
include all patients with valid assessments at any time point, adjusted for time to follow-up (4/6 months) and intra-cluster eﬀects at the nursing home level.
* Signiﬁcant association at p< .05 level.
a P for interaction is a test for diﬀerence in eﬀect between the separate groups.
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higher levels of depression. Similar results have been reported pre-
viously, possibly due to inconclusive eﬃcacy combined with increased
likelihood of prescribing to those with severe depressive symptoms
(Borza et al., 2015). While the eﬃcacy of antidepressants for depression
in people with dementia is uncertain and may be diﬃcult to assess,
elderly patients with dementia are also particularly susceptible to
adverse eﬀects and drug interactions (Gulla et al., 2016). Increased
risks of seizures, falls, fractures, and mortality have been reported in
older patients receiving antidepressants (Bakken et al., 2013; Coupland
et al., 2011).
The therapeutic beneﬁt of analgesic and antidepressant drugs
should be assessed regularly with validated tools, and weighed carefully
against potential adverse eﬀects. Future advances should go towards
systematic symptom assessment in people with dementia, in order to
identify those in need of treatment, and to stop unnecessary or harmful
treatment.
4.2. Limitations
This study has its limitations. Due to the observational design of the
study, we cannot draw conclusions on causality from this material.
Furthermore, the REDIC and COSMOS trials had diﬀerent inclusion
criteria. The REDIC trial, which contributed the majority of our
population, included patients at admission to nursing home care.
Thus our results may not be directly generalisable to other populations
with varying lengths of stay. Nursing home admission is associated with
increase of depressive symptoms, which may not be congruent with
depressive disorder (Achterberg et al., 2006). However, the persistence
rate of depression 6 months after admission has been estimated to 63%
(Smalbrugge et al., 2006), which is similar to that found in other studies
(Selbaek et al., 2013), and to our observed rate (67%). The proportion
of recently admitted patients could also strengthen our results, as the
length of stay in nursing home care is typically short. A UK study found
that 53% died within 6 months of admission, while a small number of
patients stayed much longer, increasing the average stay to 14 months
(Kelly et al., 2010). Though time to follow-up diﬀered between the
REDIC and COSMOS trials, the mixed model analyses included a time
variable to ensure that this did not aﬀect the results. The main analyses
(Table 4) were re-calculated separately for each group, with unchanged
results. The combined data set enabled us to include a high number of
patients, recruited from a wide network of research centres, controlling
for possible confounding factors to ensure robustness of results. Some
potential sources of confounding remain. The number of scheduled
prescriptions for any analgesic or antidepressant was recorded at each
time point, but we did not assess the duration of use, appropriateness of
the prescribed dose, or changes in the prescribed doses of individual
drugs. Nor did we assess any use of as-needed drugs. Furthermore, use
of nonpharmacological interventions for either pain or depression was
not assessed. While the CSDD scale includes some items that may
overlap with pain, such as “multiple physical complaints”, pain was
signiﬁcantly associated with NPI depression, reducing the likelihood
that our results are due to symptom overlap.
5. Conclusion
We found highly signiﬁcant, prospective associations between pain
and depression, irrespective of analgesic or antidepressant use. These
associations were replicated in groups with mild, moderate, and severe
cognitive impairment. Because a reduction in pain was associated with
less depressive symptoms, patients with dementia should be regularly
assessed for untreated pain. The beneﬁt of analgesic or antidepressant
drugs should also be assessed regularly and weighed carefully against
the potential for adverse eﬀects.
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